Decoy Therapeutics Inc
DCOY Healthcare Biotechnology
In the quarter to June 2026, revenue fell 84.6%, EPS grew 94.5% and free cash flow fell 212.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow DCOY
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
10.71 | 2.43 | 5.90 | 12.11 | 29.21 | 11.12 | 3.74 | 6.13 | 33.32 | 61.08 |
Receivables |
— | — | — | 1.61 | — | 3.86 | — | 0.01 | 0.01 | 0.01 |
Inventory |
— | — | — | — | — | — | — | — | 0.43 | 0.45 |
Total current assets |
10.99 | 2.99 | 6.52 | 14.52 | 30.16 | 15.80 | 4.69 | 6.38 | 34.54 | 62.47 |
Property, Plant, Equpment (Net) |
0.04 | — | — | — | 0.01 | 0.02 | 0.03 | 0.04 | 0.33 | 0.56 |
Long-term receivables |
— | — | — | — | 1.61 | — | — | — | — | — |
Goodwill and Intangible Assets (Total) |
— | — | — | — | 8.87 | 8.87 | 8.87 | — | — | — |
Long-term assets (Other) |
0.03 | 0.04 | 0.07 | 0.13 | 0.19 | 0.25 | 0.31 | 0.20 | 0.13 | 0.19 |
Total non-current assets |
0.07 | 0.04 | 0.07 | 0.13 | 10.67 | 9.14 | 9.20 | 0.23 | 0.46 | 0.75 |
Total Assets |
11.06 | 3.02 | 6.59 | 14.65 | 40.83 | 24.93 | 13.89 | 6.61 | 34.99 | 63.22 |
Notes Payable |
— | 0.22 | 0.29 | — | — | 0.48 | 0.50 | — | — | — |
Accounts Payable |
0.94 | 0.94 | 0.60 | 2.86 | 1.54 | 1.85 | 1.79 | 0.38 | 2.00 | 1.19 |
Accrued Expenses |
0.86 | 0.35 | 0.41 | 1.41 | 0.57 | 0.38 | 0.16 | 0.63 | 3.71 | 2.59 |
Current Revenue (Deferred) |
3.23 | — | — | — | — | — | 0.54 | 4.01 | 0.13 | 0.11 |
Other current liabilities |
0.00 | — | — | 1.41 | 0.57 | 0.44 | 0.32 | 7.51 | 3.84 | 2.70 |
Total current liabilities |
5.17 | 1.51 | 1.30 | 4.27 | 2.11 | 2.24 | 3.31 | 7.88 | 5.85 | 3.89 |
Long Term Debt (Total) |
— | — | — | — | — | 0.48 | — | — | — | — |
Non-current Revenue (Deferred) |
— | — | — | — | — | — | — | — | 0.04 | 0.01 |
Non-current Liabilities (Other) |
— | — | — | — | — | 0.06 | — | — | 0.04 | — |
Total non-current liabilities |
— | — | — | — | 0.01 | 0.54 | — | — | 0.04 | 0.01 |
Total liabilities |
5.17 | 1.51 | 1.30 | 4.27 | 2.11 | 2.77 | 3.31 | 7.88 | 5.89 | 3.90 |
Additional Paid In Capital |
100.33 | 83.44 | 81.64 | 74.19 | 70.92 | 41.59 | 22.66 | 3.87 | 140.18 | 135.96 |
Common Stock (Net) |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Retained Earnings |
(94.44) | (81.92) | (76.35) | (63.81) | (32.20) | (19.43) | (12.08) | (5.14) | (111.08) | (76.65) |
Common Equity (Total) |
5.89 | 1.51 | 5.29 | 10.38 | 38.72 | 22.16 | 10.58 | (1.27) | 29.11 | 59.32 |
Shareholders Equity (Total) |
5.89 | 1.51 | 5.29 | 10.38 | 38.72 | 22.16 | 10.58 | (1.27) | 29.11 | 59.32 |
Shareholders Equity and Liabilities (Total) |
11.06 | 3.02 | 6.59 | 14.65 | 40.83 | 24.93 | 13.89 | 6.61 | 34.99 | 63.22 |
Shares (Common) |
0.53 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.80 | 16.77 |
Shares (Preferred) |
0.00 | 0.00 | — | — | — | — | — | — | — | — |
Shareholders Equity (Tangible) |
5.89 | 1.51 | 5.29 | 10.38 | 29.86 | 13.29 | 1.71 | (1.27) | 29.11 | 59.32 |
Net Debt |
(10.71) | (2.43) | (5.90) | (12.11) | (29.21) | (10.64) | (3.74) | (6.13) | (33.32) | (61.07) |
Total Debt |
— | — | — | — | — | 0.48 | 0.50 | — | — | — |